施贵宝(BMY)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

BMY 施贵宝

盘前交易 10-19 04:39:37 EDT

59.75

-0.82

-1.35%

盘前59.60

-0.15-0.25%

04:37 EDT

最高61.43	最低59.54	成交量1,377万
今开61.10	昨收60.57	日振幅3.12%
总市值1,216亿	流通市值1,214亿	总股本20.36亿
成交额8.28亿	换手率0.68%	流通股本20.32亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"BMY","market":"US","secType":"STK","nameCN":"施贵宝","latestPrice":59.75,"timestamp":1792180800000,"preClose":60.57,"halted":0,"volume":13771602,"hourTrading":{"tag":"盘前","latestPrice":59.6,"preClose":59.75,"latestTime":"04:37 EDT","volume":190,"amount":11324.88977,"timestamp":1792399036336,"change":-0.15,"changeRate":-0.00251,"amplitude":0.030003},"delay":0,"changeRate":-0.013538055142809976,"floatShares":2031646263,"shares":2035753027,"eps":4.542906,"marketStatus":"盘前交易","change":-0.82,"latestTime":"10-19 04:39:37 EDT","open":61.1,"high":61.4273,"low":59.54,"amount":828436956.845706,"amplitude":0.031159,"askPrice":60.46,"askSize":820,"bidPrice":59.6,"bidSize":10,"shortable":3,"etf":0,"ttmEps":4.542906,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1792416600000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":-18475200000,"exchange":"NYSE","adjPreClose":59.75,"dividendRate":0.042008,"preHourTrading":{"tag":"盘前","latestPrice":59.6,"preClose":59.75,"latestTime":"04:37 EDT","volume":190,"amount":11324.88977,"timestamp":1792399036336,"change":-0.15,"changeRate":-0.00251,"amplitude":0.030003},"postHourTrading":{"tag":"盘后","latestPrice":60.1872,"preClose":59.75,"latestTime":"19:55 EDT","volume":1611965,"amount":96315982.4975,"timestamp":1792194925813,"change":0.4372,"changeRate":0.007317,"amplitude":0.007699},"volumeRatio":0.8990713144805189,"optionData":{"bulkOrders":[{"symbol":"BMY","call":true,"expireDate":1794546000000,"strike":"67.0","timestamp":1792162122938,"price":0.52,"volume":1500,"amount":78000,"type":"+"}]},"impliedVol":0.3549,"impliedVolPercentile":0.856},"requestUrl":"/m/hq/s/BMY","defaultTab":"news","newsList":[{"id":"2676703085","title":"汇丰：将诺和诺德目标价从320丹麦克朗下调至280丹麦克朗；将百时美施贵宝目标价从65美元下调至60美元；将阿斯利康目标","url":"https://stock-news.laohu8.com/highlight/detail?id=2676703085","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676703085?lang=zh_cn&edition=full","pubTime":"2026-10-19 13:18","pubTimestamp":1792387119,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0225771236.USD","LU1430594728.SGD","LU1571399168.USD","IHE","LU0882574055.USD","LU0225284248.USD","LU1670711040.USD","LU0456855351.SGD","LU0321505439.SGD","LU2360032135.SGD","LU1093756325.SGD","BK4532","LU0114720955.EUR","IE00B2B36J28.USD","LU1670710588.SGD","LU0306807586.USD","BMY","BK4007","LU0096364046.USD","LU1868836914.USD","LU1093756168.USD","BK4559","LU1983299246.USD","LU0237698245.USD","LU1718418525.SGD","LU1236620750.USD","LU2242646821.SGD","IE00BJT1NW94.SGD","BK4585","LU2133065610.SGD","IE00BJJMRZ35.SGD","FTXH","IE0009355771.USD","UDN","LU1074936037.SGD","LU2125154778.USD","BK4588","LU0061475181.USD","UUP","LU1868836757.USD","LU2596442595.SGD","LU0321505868.SGD","LU2125154935.USD","LU1585245621.USD","BGIA","BK4534","IE0002141913.USD","BK4581","LU0868494617.USD","PRTO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160526008","title":"美股异动｜美股药品制造商板块逆市走强，阿斯利康、施贵宝、礼来涨超4%","url":"https://stock-news.laohu8.com/highlight/detail?id=1160526008","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1160526008?lang=zh_cn&edition=full","pubTime":"2026-10-15 22:07","pubTimestamp":1792073252,"startTime":"0","endTime":"0","summary":"美股药品制造商板块逆市走强，阿斯利康、施贵宝、礼来涨超4%，葛兰素史克、诺和诺德、诺华制药涨超3%，强生、辉瑞、默沙东、艾伯维涨超2%。","market":"us","thumbnail":"https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LLY","LLYX","ELIL","ELIS","AZN","BMY","LLII"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134465997","title":"异动解读｜施贵宝盘中上涨3.64%，两款三期临床进展持续发酵","url":"https://stock-news.laohu8.com/highlight/detail?id=1134465997","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1134465997?lang=zh_cn&edition=full","pubTime":"2026-10-15 21:54","pubTimestamp":1792072478,"startTime":"0","endTime":"0","summary":"10月15日，施贵宝盘中上涨3.64%，报61.91美元/股，成交额1.07亿美元。消息面上，市场继续消化公司两项三期研究的积极结果，带动创新管线价值重估。其中，Admilparant在ALOFT-IPF试验中，60毫克剂量组达到52周用力肺活量主要终点；RayzeBio放射性药物RYZ101三期研究期中分析也达到主要终点，显著改善无进展生存期。公司此前还表示，一例高剂量组患者死亡事件很可能与治疗无关。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"施贵宝三期进展积极，股价显著上涨","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185342260","title":"异动解读｜施贵宝盘中上涨3.03%，两款三期临床进展持续发酵","url":"https://stock-news.laohu8.com/highlight/detail?id=1185342260","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1185342260?lang=zh_cn&edition=full","pubTime":"2026-10-15 00:07","pubTimestamp":1791994026,"startTime":"0","endTime":"0","summary":"10月15日，施贵宝盘中上涨3.03%，报58.385美元/股，成交额2.24亿美元。消息面上，公司此前披露两项三期研究取得积极结果，市场继续消化其创新管线价值。其中特发性肺纤维化药物Admilparant在ALOFT-IPF试验中，60毫克剂量组达到52周用力肺活量主要终点；同时，RayzeBio的放射性药物RYZ101三期研究期中分析也达到主要终点，显著改善无进展生存期。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"施贵宝大幅上涨，三期临床利好发酵","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675387736","title":"杰富瑞将百时美施贵宝公司目标价从73美元上调至76美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2675387736","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675387736?lang=zh_cn&edition=full","pubTime":"2026-10-13 12:11","pubTimestamp":1791864715,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["UDN","LU1093756168.USD","LU1236620834.HKD","IE00BFXG1179.USD","LU0456855351.SGD","LU1983299246.USD","LU1670710588.SGD","LU1718418525.SGD","LU1323610961.USD","LU0225771236.USD","BK4007","LU1868836757.USD","LU2133065610.SGD","LU0114720955.EUR","LU1236620750.USD","IHE","IE0009355771.USD","IE00BJT1NW94.SGD","LU1571399168.USD","LU1032466523.USD","LU1868837300.USD","LU1989771016.USD","IE0002141913.USD","LU0306807586.USD","LU2242646821.SGD","LU0096364046.USD","UUP","LU1670711123.USD","LU1430594728.SGD","LU1868836591.USD","LU0267386448.USD","LU0225284248.USD","LU0868494617.USD","BK4532","IE00BJJMRZ35.SGD","LU0061475181.USD","LU0432979614.USD","LU1868837136.USD","BK4559","LU0321505868.SGD","LU2360032135.SGD","BMY","BK4585","LU2596442595.SGD","FTXH","IE00BFTCPJ56.SGD","LU1585245621.USD","LU1868836914.USD","LU1670710661.SGD","LU1291159041.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109602368","title":"异动解读｜施贵宝盘中下跌3.36%，两款三期临床成功难抵卖压","url":"https://stock-news.laohu8.com/highlight/detail?id=1109602368","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1109602368?lang=zh_cn&edition=full","pubTime":"2026-10-12 22:04","pubTimestamp":1791813888,"startTime":"0","endTime":"0","summary":"10月12日，施贵宝盘中下跌3.36%，报57.14美元/股，成交额2.66亿美元。消息面上，公司同日公布Admilparant治疗特发性肺纤维化的三期ALOFT-IPF试验在60毫克剂量组达到用力肺活量主要终点，且RYZ101放射性药物疗法的三期研究亦达到主要终点。两项关键管线进展虽属利好，但股价仍出现回落，反映市场在消化此前盘前涨幅后出现获利了结。百时美施贵宝公司是一家全球性生物制药企业，专注肿瘤学、血液学、免疫学、心血管和神经科学领域的创新药物研发与销售。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"施贵宝三期临床双喜，股价却遭获利回吐","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674701808","title":"百时美施贵宝股价上涨2.2%，此前该公司的癌症疗法在后期研究中达到主要目标，其肺病药物也在试验中显示出获益。","url":"https://stock-news.laohu8.com/highlight/detail?id=2674701808","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674701808?lang=zh_cn&edition=full","pubTime":"2026-10-12 21:33","pubTimestamp":1791812011,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0114720955.EUR","LU0225284248.USD","LU1670710661.SGD","IE00BJJMRZ35.SGD","LU1236620750.USD","LU2596442595.SGD","LU1868836914.USD","LU2242646821.SGD","LU2360032135.SGD","LU1989771016.USD","IE00BFXG1179.USD","LU1093756325.SGD","LU0225771236.USD","LU1291159041.SGD","LU1670710588.SGD","LU1585245621.USD","BK4585","LU1430594728.SGD","LU1093756168.USD","IHE","LU1868836757.USD","LU0868494617.USD","LU0237698245.USD","LU2133065610.SGD","LU1032466523.USD","IE00BFTCPJ56.SGD","LU0306807586.USD","LU1670711040.USD","BK4532","IE0009355771.USD","LU0321505868.SGD","LU0267386448.USD","LU0985481810.HKD","LU0306806265.USD","LU0321505439.SGD","IE00B2B36J28.USD","LU1261432733.SGD","LU1323610961.USD","BK4007","LU0456855351.SGD","BK4559","LU1868837300.USD","BK4588","LU1074936037.SGD","LU0432979614.USD","LU1983299246.USD","LU1236620834.HKD","BMY","FTXH","LU0096364046.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674006877","title":"百时美施贵宝(BMY.US)盘前走高！两款实验性药物三期临床齐传捷报 管线多元化加速","url":"https://stock-news.laohu8.com/highlight/detail?id=2674006877","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674006877?lang=zh_cn&edition=full","pubTime":"2026-10-12 20:26","pubTimestamp":1791807963,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，百时美施贵宝用于治疗一种罕见内分泌癌症和一种致命肺病的两款实验性药物，在三期临床研究中取得成功，为这家制药公司的新产品管线注入动力。受此消息提振，截至发稿，百时美施贵宝周一美股盘前涨近4%。百时美施贵宝表示，LPA1拮抗剂Admilparant治疗特发性肺纤维化的三期临床ALPFT-IPF试验达到FVC主要终点。百时美施贵宝正将管线多元化作为布局战略，以应对多款关键产品专利到期带来的冲击。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1506129.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE0009355771.USD","LU2360032135.SGD","LU1670710588.SGD","IE00BFTCPJ56.SGD","LU0321505868.SGD","BK4534","BK4007","FTXH","LU1868836757.USD","LU1868836914.USD","LU1093756325.SGD","LU0061475181.USD","IE00BSNM7G36.USD","LU0306807586.USD","LU1261432733.SGD","LU1323610961.USD","LU2125154935.USD","LU1430594728.SGD","IHE","LU1983299246.USD","LU1989771016.USD","BK4585","LU1670710661.SGD","LU1670711040.USD","LU1718418525.SGD","LU0868494617.USD","LU0114720955.EUR","BK4532","LU1868837136.USD","LU2125154778.USD","LU1883839398.USD","LU2242652126.USD","LU1571399168.USD","BMY","BK4581","LU1236620750.USD","IE00BJJMRZ35.SGD","LU1291159041.SGD","IE0002141913.USD","LU1868837300.USD","IE00BJT1NW94.SGD","IE00B2B36J28.USD","LU0267386448.USD","LU0225284248.USD","LU0225771236.USD","LU1032466523.USD","LU0321505439.SGD","LU0985481810.HKD","LU0882574055.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674871721","title":"百时美施贵宝美股盘前涨超5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2674871721","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674871721?lang=zh_cn&edition=full","pubTime":"2026-10-12 18:57","pubTimestamp":1791802636,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU1430594728.SGD","LU1571399168.USD","IHE","LU0225284248.USD","LU2360032135.SGD","LU0456855351.SGD","LU0321505439.SGD","BK4532","LU0114720955.EUR","IE00B2B36J28.USD","LU1868836591.USD","LU1670710588.SGD","LU2242652126.USD","LU0306807586.USD","BMY","BK4007","LU0096364046.USD","LU1670710661.SGD","LU1868836914.USD","LU1093756168.USD","BK4559","LU1983299246.USD","LU0306806265.USD","LU0432979614.USD","LU1868837136.USD","LU0237698245.USD","LU1718418525.SGD","LU1236620750.USD","IE00BJT1NW94.SGD","BK4581","LU1236620834.HKD","FTXH","IE0009355771.USD","LU1883839398.USD","LU1989771016.USD","LU1074936037.SGD","LU2125154778.USD","BK4588","IE00BFTCPJ56.SGD","IE00BFXG1179.USD","LU0061475181.USD","LU1868836757.USD","LU2596442595.SGD","LU0267386448.USD","LU1585245621.USD","BK4534","IE0002141913.USD","BK4585","LU0868494617.USD","LU1032466523.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169911067","title":"异动解读｜施贵宝盘前上涨4.25%，Admilparant肺纤维化3期试验达到主要终点","url":"https://stock-news.laohu8.com/highlight/detail?id=1169911067","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1169911067?lang=zh_cn&edition=full","pubTime":"2026-10-12 18:57","pubTimestamp":1791802634,"startTime":"0","endTime":"0","summary":"10月12日，施贵宝盘前上涨4.25%，报61.35美元，成交额72.27万美元。消息面上，公司宣布Admilparant在特发性肺纤维化3期长期扩展研究中，60毫克剂量组用药第52周时用力肺活量改善效果相较于安慰剂具备统计学显著性，研究达到主要终点。该结果对施贵宝具有重要管线意义，因Admilparant被视为公司在呼吸系统疾病领域的关键资产。本次Admilparant数据公布为盘前股价提供了直接催化。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"施贵宝盘前上涨，肺纤维化新药达主要终点","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674712358","title":"百时美施贵宝公司：Admilparant 60毫克剂量用药第52周，用力肺活量改善效果相较于安慰剂具备统计学显著性。","url":"https://stock-news.laohu8.com/highlight/detail?id=2674712358","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674712358?lang=zh_cn&edition=full","pubTime":"2026-10-12 18:50","pubTimestamp":1791802234,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU1585245621.USD","BK4532","LU1670710588.SGD","LU2125154935.USD","LU0321505868.SGD","LU1032466523.USD","LU1323610961.USD","LU2133065610.SGD","LU2242652126.USD","LU1074936037.SGD","BK4534","LU1670711040.USD","LU1718418525.SGD","BMY","LU1868837300.USD","BK4559","LU0237698245.USD","LU0225771236.USD","LU1261432733.SGD","LU0267386448.USD","IE00BJT1NW94.SGD","LU0456855351.SGD","IE00BSNM7G36.USD","IHE","LU1868837136.USD","BK4007","LU1989771016.USD","IE0009355771.USD","LU1236620750.USD","LU1236620834.HKD","LU0432979614.USD","PRTO","LU0114720955.EUR","IE00BFTCPJ56.SGD","LU1868836591.USD","LU1868836757.USD","LU1571399168.USD","BK4585","FTXH","LU0061475181.USD","LU0321505439.SGD","IE00B2B36J28.USD","BK4581","IE0002141913.USD","LU0306807586.USD","LU0882574055.USD","LU1093756168.USD","LU1093756325.SGD","LU2242646821.SGD","IE00BFXG1179.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674239871","title":"百时美施贵宝：研究达到主要终点。","url":"https://stock-news.laohu8.com/highlight/detail?id=2674239871","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674239871?lang=zh_cn&edition=full","pubTime":"2026-10-12 18:50","pubTimestamp":1791802209,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0456855351.SGD","LU1093756325.SGD","LU0432979614.USD","LU1670711123.USD","LU2125154935.USD","LU0321505439.SGD","LU1868837136.USD","LU0868494617.USD","LU1585245621.USD","LU1670711040.USD","IE00BJT1NW94.SGD","IE00BSNM7G36.USD","LU0306806265.USD","LU0267386448.USD","IE00BFXG1179.USD","LU2242646821.SGD","LU1868836591.USD","LU1291159041.SGD","IE0009355771.USD","LU0321505868.SGD","LU1571399168.USD","LU2242652126.USD","LU1261432733.SGD","LU1868837300.USD","LU1718418525.SGD","BK4588","LU0061475181.USD","BK4007","LU0985481810.HKD","LU2360032135.SGD","IE00BFTCPJ56.SGD","IHE","LU1093756168.USD","LU0114720955.EUR","LU1074936037.SGD","LU1670710588.SGD","LU1989771016.USD","LU0882574055.USD","LU1670710661.SGD","LU0306807586.USD","IE0002141913.USD","BK4534","BK4532","LU1236620750.USD","LU2125154778.USD","LU1868836757.USD","LU0225771236.USD","BK4559","BMY","FTXH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673870070","title":"施贵宝（BMY）骨髓瘤新药3期试验成功 可显著降低疾病进展死亡风险","url":"https://stock-news.laohu8.com/highlight/detail?id=2673870070","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673870070?lang=zh_cn&edition=full","pubTime":"2026-10-08 20:49","pubTimestamp":1791463785,"startTime":"0","endTime":"0","summary":"金吾财讯 | 施贵宝 周四公布，包含Zenbexus的联合疗法在3期EXCALIBER-RRMM临床试验中取得积极顶线结果。Zenbexus是一款针对罕见血液癌症多发性骨髓瘤的药物，已于今年8月获美国FDA加速批准上市，获批依据为微小残留病灶阴性完全缓解这一双主要终点指标。研究达成对比标准治疗的双主要终点无进展生存期：Zenbexus联合治疗组中位无进展生存期42个月，标准治疗组为20个月；中位随访23个月条件下，该联合方案将患者疾病进展或死亡风险降低51%。","market":"nz","thumbnail":"https://static.szfiu.com/news/20250107/MWRmODAzMDJiNzRkNTY3ODIxNTExMzM=.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/MWRmODAzMDJiNzRkNTY3ODIxNTExMzM=.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"306986","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0234570918.USD","FTXH","LU2089984988.USD","LU0306807586.USD","LU0882574055.USD","IE00B1BXHZ80.USD","IE00BVYPNV92.GBP","JNJ","MEDX","LU0072461881.USD","LU1261432733.SGD","LU1894683264.USD","PJP","LU1670710588.SGD","FHLC","LU0203347892.USD","LU1121112475.USD","LU1571399168.USD","IE00B4R5TH58.HKD","IHE","LU1032466523.USD","IE00B2B36J28.USD","LU2236285917.USD","IYH","LU0985481810.HKD","GDOC","BMY","RXL","JDOC","BMED","LU1983299246.USD","LU0237698245.USD","XLV","LU2468319806.SGD","LU0949170772.SGD","LU2347655156.SGD","IXJ","LU0994945656.USD","TRUH","LU0545562505.USD","LU1868837136.USD","LU2129689431.USD","LU0069063385.USD","VHT","BK4504","SG9999013999.USD","LU1244550577.SGD","LU0070217475.USD","BK4532","LU0683600562.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171992181","title":"异动解读｜施贵宝盘中下跌3.03%，遭机构下调评级及目标价","url":"https://stock-news.laohu8.com/highlight/detail?id=1171992181","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1171992181?lang=zh_cn&edition=full","pubTime":"2026-10-05 22:03","pubTimestamp":1791209001,"startTime":"0","endTime":"0","summary":"10月5日，施贵宝盘中下跌3.03%，报59.29美元。主要原因系Leerink Partners将其评级从‘跑赢大盘’下调至‘大盘’，目标价由73美元大幅调降至59美元。此项调整反映了分析机构对该公司近期研发管线风险及市场竞争压力的谨慎评估。百时美施贵宝公司于1887年创立，专注于肿瘤学、血液学及免疫学等领域的创新药物研发，产品销往全球并通过特药药房等渠道覆盖患者群体。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1190206250","title":"百利天恒子公司获施贵宝2.5亿美元里程碑付款，伊扎-布伦协议推进顺利","url":"https://stock-news.laohu8.com/highlight/detail?id=1190206250","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1190206250?lang=zh_cn&edition=full","pubTime":"2026-09-21 19:17","pubTimestamp":1789989431,"startTime":"0","endTime":"0","summary":"百利天恒宣布，其下属子公司已收到来自施贵宝的2.5亿美元里程碑付款。这笔资金与双方签署的伊扎-布伦协议相关，标志着合作项目取得阶段性重大进展。百利天恒方面表示，此次里程碑付款的落实，是两家企业深化战略伙伴关系的关键一步，同时也为创新药管线的价值释放奠定了坚实基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1430594728.SGD","IE00B2B36J28.USD","LU0432979614.USD","IE00BFTCPJ56.SGD","LU0321505439.SGD","IE00BJT1NW94.SGD","LU1291159041.SGD","LU1670711123.USD","LU1868836914.USD","LU1032466523.USD","LU2125154778.USD","LU1868837300.USD","LU1670710661.SGD","BK0239","IHE","LU1868836591.USD","LU1323610961.USD","LU1074936037.SGD","LU2596442595.SGD","LU0267386448.USD","LU1093756325.SGD","LU0985481810.HKD","LU1585245621.USD","LU1883839398.USD","688506","LU0456855351.SGD","LU0237698245.USD","LU1236620834.HKD","IE00BFXG1179.USD","LU2125154935.USD","BK4007","LU0096364046.USD","IE00BJJMRZ35.SGD","LU1261432733.SGD","LU1670711040.USD","BK4588","BK4532","LU0882574055.USD","BK4559","LU1236620750.USD","BK4581","LU1868836757.USD","LU0225284248.USD","LU2360032135.SGD","BK4585","LU2242646821.SGD","LU0306806265.USD","LU0306807586.USD","IE0009355771.USD","IE0002141913.USD","LU0114720955.EUR","LU0868494617.USD","LU1670710588.SGD","LU1989771016.USD","IE00BSNM7G36.USD","LU2133065610.SGD","BK4534","FTXH","LU0321505868.SGD","LU1093756168.USD","LU1983299246.USD","LU0061475181.USD","LU1571399168.USD","LU2242652126.USD","LU1868837136.USD","LU1718418525.SGD","LU0225771236.USD","BMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668394012","title":"百时美施贵宝将于2026年10月29日公布2026年第三季度业绩。","url":"https://stock-news.laohu8.com/highlight/detail?id=2668394012","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668394012?lang=zh_cn&edition=full","pubTime":"2026-09-18 18:59","pubTimestamp":1789729172,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU1074936037.SGD","LU1032466523.USD","LU0432979614.USD","LU1868836914.USD","IE00B2B36J28.USD","LU0237698245.USD","LU0985481810.HKD","LU0061475181.USD","LU1323610961.USD","LU2242652126.USD","LU1291159041.SGD","LU1868837300.USD","BK4532","BK4585","LU1093756168.USD","IE00BSNM7G36.USD","LU2242646821.SGD","IHE","IE00BJT1NW94.SGD","IE0009355771.USD","LU1989771016.USD","LU1261432733.SGD","BK4588","LU0225284248.USD","LU1093756325.SGD","LU1718418525.SGD","LU1868836757.USD","LU0267386448.USD","IE00BFXG1179.USD","FTXH","LU0321505868.SGD","LU2125154778.USD","LU0114720955.EUR","LU1585245621.USD","LU1883839398.USD","BK4007","IE0002141913.USD","BMY","LU0306806265.USD","LU2360032135.SGD","BK4581","BK4534","LU0456855351.SGD","LU1571399168.USD","LU2133065610.SGD","BK4559","LU1670710661.SGD","LU2596442595.SGD","LU1983299246.USD","LU1236620834.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668948847","title":"Piper Sandler上调百时美施贵宝目标价至82美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2668948847","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668948847?lang=zh_cn&edition=full","pubTime":"2026-09-18 14:29","pubTimestamp":1789712992,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU1430594728.SGD","IE00BFTCPJ56.SGD","LU0321505439.SGD","IE00BJT1NW94.SGD","LU1291159041.SGD","LU1670711123.USD","LU1032466523.USD","LU1868837300.USD","LU1868836591.USD","IHE","LU1323610961.USD","LU1074936037.SGD","LU2596442595.SGD","LU0267386448.USD","LU1093756325.SGD","LU0985481810.HKD","LU1883839398.USD","LU0456855351.SGD","LU2125154935.USD","BK4007","LU0096364046.USD","LU1670711040.USD","BK4588","UUP","BK4532","LU0882574055.USD","BK4559","LU1868836757.USD","BK4581","LU2360032135.SGD","LU0225284248.USD","BK4585","LU2242646821.SGD","LU0306807586.USD","IE0009355771.USD","IE0002141913.USD","LU0114720955.EUR","LU1670710588.SGD","LU1989771016.USD","IE00BSNM7G36.USD","FTXH","LU0321505868.SGD","LU1093756168.USD","LU1983299246.USD","UDN","LU1571399168.USD","LU1868837136.USD","LU1718418525.SGD","LU0225771236.USD","BMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139471658","title":"施贵宝公布Sotyktu（Deucravacitinib）两年临床数据：银屑病关节炎成人患者疗效持久且安全性稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1139471658","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1139471658?lang=zh_cn&edition=full","pubTime":"2026-09-17 19:00","pubTimestamp":1789642811,"startTime":"0","endTime":"0","summary":"施贵宝近日披露了其重磅药物Sotyktu的最新研究结果。数据表明，在成人银屑病关节炎患者群体中，这款口服疗法的疗效可持续长达两年之久，且其安全性特征保持一致。此番公布的临床数据，为Sotyktu在长期管理该慢性炎症性疾病方面的潜力增添了有力佐证。这进一步巩固了Deucravacitinib作为一种耐受性良好的长期治疗选项的地位。施贵宝公司表示，这些发现不仅加深了医学界对Sotyktu作用机制的理解，也为临床医生在制定长期治疗策略时提供了更为坚实的数据支撑。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0114720955.EUR","LU0225284248.USD","LU1718418525.SGD","LU0882574055.USD","IE00BJJMRZ35.SGD","BK4534","LU1236620750.USD","LU1670710661.SGD","LU2596442595.SGD","LU1868836914.USD","LU2242646821.SGD","LU2360032135.SGD","LU2125154935.USD","LU2242652126.USD","LU1989771016.USD","IE00BFXG1179.USD","LU1670711123.USD","LU1868836591.USD","LU0061475181.USD","LU0225771236.USD","LU1093756325.SGD","LU1291159041.SGD","LU1670710588.SGD","LU1585245621.USD","IE00BJT1NW94.SGD","BK4585","LU1430594728.SGD","LU1093756168.USD","IHE","LU1868836757.USD","LU0868494617.USD","LU0237698245.USD","LU2133065610.SGD","LU1032466523.USD","LU1868837136.USD","IE00BFTCPJ56.SGD","LU0306807586.USD","LU1670711040.USD","BK4532","IE0009355771.USD","LU0321505868.SGD","LU0267386448.USD","LU0985481810.HKD","LU0306806265.USD","LU0321505439.SGD","IE00B2B36J28.USD","LU1261432733.SGD","LU1323610961.USD","BK4007","LU0456855351.SGD","BK4559","LU1868837300.USD","BK4588","LU2125154778.USD","LU1074936037.SGD","LU0432979614.USD","LU1883839398.USD","BK4581","LU1983299246.USD","IE0002141913.USD","LU1236620834.HKD","BMY","FTXH","IE00BSNM7G36.USD","LU0096364046.USD","LU1571399168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667607482","title":"百时美施贵宝公司宣布，派发季度股息，每股派0.63美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2667607482","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667607482?lang=zh_cn&edition=full","pubTime":"2026-09-16 18:59","pubTimestamp":1789556361,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU1032466523.USD","LU1868837300.USD","LU1670711123.USD","BMY","LU1670710588.SGD","LU1983299246.USD","BK4534","LU0225284248.USD","LU1261432733.SGD","VIG","LU2596442595.SGD","UUP","IHE","IE00BJJMRZ35.SGD","BK4007","LU1323610961.USD","LU0237698245.USD","LU2242652126.USD","LU1670711040.USD","LU1718418525.SGD","LU0096364046.USD","BK4581","LU1868836591.USD","LU0225771236.USD","FTXH","LU1236620834.HKD","LU1236620750.USD","LU1989771016.USD","LU0882574055.USD","UDN","IE00BFXG1179.USD","LU1670710661.SGD","LU0321505439.SGD","LU0432979614.USD","LU2125154778.USD","BK4559","LU1291159041.SGD","LU1585245621.USD","LU2242646821.SGD","IE00BJT1NW94.SGD","LU1868836914.USD","LU1883839398.USD","LU0306806265.USD","BK4588","LU0114720955.EUR","LU0321505868.SGD","IE0002141913.USD","IE0009355771.USD","IE00BFTCPJ56.SGD","LU1868837136.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667267605","title":"百时美施贵宝就安进拟推出的Opdivo生物类似药提起诉讼","url":"https://stock-news.laohu8.com/highlight/detail?id=2667267605","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667267605?lang=zh_cn&edition=full","pubTime":"2026-09-16 10:15","pubTimestamp":1789524901,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["IE00B4R5TH58.HKD","LU1868836591.USD","IBBQ","LU1992135399.USD","LU0058720904.USD","LU0109394709.USD","BMY","IE0009355771.USD","LU1868836757.USD","LU0868494617.USD","LU2473716301.USD","PJP","BK4588","LU2322448957.HKD","XPH","LU2468319806.SGD","LU1236620750.USD","LU2125154778.USD","LU0225771236.USD","BK4533","BK4534","LU0114720955.EUR","LU1989771016.USD","BBH","TBXU","AMGN","LU1670711123.USD","PBE","LU1236620834.HKD","BK4559","LU2272731865.HKD","LU1868837300.USD","BK4585","LU0289739699.SGD","LU0061475181.USD","PPH","IHE","IE00BSNM7G36.USD","BK4566","BIB","FTXH","LU0320765992.SGD","LU1023059063.AUD","LU1261432733.SGD","BK4139","LU1983299246.USD","IBB","LU0225284248.USD","LU2272731600.USD","LU1883839398.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.bms.com","stockEarnings":[{"period":"1week","weight":0.0107},{"period":"1month","weight":-0.0605},{"period":"3month","weight":-0.0163},{"period":"6month","weight":-0.007},{"period":"1year","weight":0.377},{"period":"ytd","weight":0.1077}],"compareEarnings":[{"period":"1week","weight":-0.0197},{"period":"1month","weight":0.0122},{"period":"3month","weight":0.0269},{"period":"6month","weight":0.0748},{"period":"1year","weight":0.1553},{"period":"ytd","weight":0.1193}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"百时美施贵宝公司于1933年8月在美国德拉瓦州注册成立，源自于1887年在纽约创办的企业，并在1989年因合并而重命名。作为一家生物制药公司，百时美施贵宝专注于创新药物的发现、开发、许可、生产、营销和销售，以对抗严重疾病。公司的战略方法结合了大型制药公司的资源和规模，以及生物技术行业特有的灵活性和创新重点。百时美施贵宝优先关注肿瘤学、血液学、免疫学、心血管和神经科学等领域的变革性药物，旨在提供长期价值和竞争优势。作为全球研究型制药公司，百时美施贵宝的产品在全球范围内销售，服务于包括批发商、分销商和特药药房在内的多种实体，并在多个国家保持着重要的生产运营。","yearOnYearQuotes":[{"month":1,"riseRate":0.478261,"avgChangeRate":-0.011323},{"month":2,"riseRate":0.565217,"avgChangeRate":0.011855},{"month":3,"riseRate":0.630435,"avgChangeRate":0.007963},{"month":4,"riseRate":0.468085,"avgChangeRate":-0.005808},{"month":5,"riseRate":0.553191,"avgChangeRate":0.001393},{"month":6,"riseRate":0.617021,"avgChangeRate":0.009381},{"month":7,"riseRate":0.425532,"avgChangeRate":0.001143},{"month":8,"riseRate":0.531915,"avgChangeRate":-0.000512},{"month":9,"riseRate":0.510638,"avgChangeRate":0.008315},{"month":10,"riseRate":0.574468,"avgChangeRate":0.023683},{"month":11,"riseRate":0.630435,"avgChangeRate":0.022318},{"month":12,"riseRate":0.630435,"avgChangeRate":0.022265}],"exchange":"NYSE","name":"施贵宝","nameEN":"Bristol-Myers Squibb"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"施贵宝(BMY)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供施贵宝(BMY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"施贵宝,BMY,施贵宝股票,施贵宝股票老虎,施贵宝股票老虎国际,施贵宝行情,施贵宝股票行情,施贵宝股价,施贵宝股市,施贵宝股票价格,施贵宝股票交易,施贵宝股票购买,施贵宝股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"施贵宝(BMY)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供施贵宝(BMY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}